Literature DB >> 27405277

Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.

Y Wang1, X D Tan1, C Zhou2, W Zhou3, J S Peng3, Y S Ren4, Z L Ni1, B Liu1, F Yang5, X D Gao6.   

Abstract

Social networks facilitate the transmission of hepatitis C virus (HCV) in people who inject drugs (PWID). The aim of this study was to assess how certain network structural characteristics are related to HCV infections in PWID and to determine the most susceptible individuals for HCV transmission in a network of PWID. PWID (N = 80) from central China were recruited from a previous follow-up case-control study. Demographic and behavioural information was obtained from a computerized database for each group. HCV RNA was extracted from blood specimens. Sequences were used to construct a phylogenetic tree and to determine genetic distances. Socio-metric social links were established between participants. Network measures were calculated using UCINET. Three HCV genotypes were identified, covering five subtypes. The density of the social networks for the whole sample (N = 80), case group (n = 31) and control group (n = 49) was 0.038, 0.054 and 0.008, respectively. PWID infected with HCV were in frequent contact with others within their group. There were four pairs of nodes with genotypic distances of 0.000 that were identified and clustered in subtypes 6a and 1b; each subject pair was linked and found in one clique. Three of the five most active nodes were infected with HCV. These three nodes served as a bridge, contributing to the connection of other nodes. These findings identify susceptible individuals for HCV transmission in PWID based on their frequent contact with others in the network. These results provide data that could be used for modelling HCV transmission patterns and in public health policies.

Entities:  

Keywords:  Genetic diversity; hepatitis C virus infection; people who inject drugs; social network analysis

Mesh:

Substances:

Year:  2016        PMID: 27405277      PMCID: PMC9150418          DOI: 10.1017/S0950268816001333

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  25 in total

1.  Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.

Authors:  Michael C Clatts; Vivian Colón-López; Le M Giang; Lloyd A Goldsamt
Journal:  J Urban Health       Date:  2010-03       Impact factor: 3.671

Review 2.  A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs.

Authors:  Holly Hagan; Enrique R Pouget; Don C Des Jarlais
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

Review 3.  Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Authors:  P Bruggmann; T Berg; A L H Øvrehus; C Moreno; C E Brandão Mello; F Roudot-Thoraval; R T Marinho; M Sherman; S D Ryder; J Sperl; U Akarca; I Balık; F Bihl; M Bilodeau; A J Blasco; M Buti; F Calinas; J L Calleja; H Cheinquer; P B Christensen; M Clausen; H S M Coelho; M Cornberg; M E Cramp; G J Dore; W Doss; A S Duberg; M H El-Sayed; G Ergör; G Esmat; C Estes; K Falconer; J Félix; M L G Ferraz; P R Ferreira; S Frankova; J García-Samaniego; J Gerstoft; J A Giria; F L Gonçales; E Gower; M Gschwantler; M Guimarães Pessôa; C Hézode; H Hofer; P Husa; R Idilman; M Kåberg; K D E Kaita; A Kautz; S Kaymakoglu; M Krajden; H Krarup; W Laleman; D Lavanchy; P Lázaro; P Marotta; S Mauss; M C Mendes Correa; B Müllhaupt; R P Myers; F Negro; V Nemecek; N Örmeci; J Parkes; K M Peltekian; A Ramji; H Razavi; N Reis; S K Roberts; W M Rosenberg; R Sarmento-Castro; C Sarrazin; D Semela; G E Shiha; W Sievert; P Stärkel; R E Stauber; A J Thompson; P Urbanek; I van Thiel; H Van Vlierberghe; D Vandijck; W Vogel; I Waked; H Wedemeyer; N Weis; J Wiegand; A Yosry; A Zekry; P Van Damme; S Aleman; S J Hindman
Journal:  J Viral Hepat       Date:  2014-05       Impact factor: 3.728

4.  Hepatitis C seroconversion in methadone maintenance treatment programs in Wuhan, China.

Authors:  Wang Zhou; Xia Wang; Sheng Zhou; Nianhua Xie; Pulin Liu; Li Luo; Jinsong Peng; Manqing Liu; Alethea Desrosiers; Richard Schottenfeld; Marek C Chawarski
Journal:  Addiction       Date:  2015-01-22       Impact factor: 6.526

5.  Sexual transmissibility of HIV among opiate users with concurrent sexual partnerships: an egocentric network study in Yunnan, China.

Authors:  Jian Li; Hongjie Liu; Jianhua Li; Jian Luo; Nana Koram; Roger Detels
Journal:  Addiction       Date:  2011-06-01       Impact factor: 6.526

6.  Hepatitis C virus risk behaviors within the partnerships of young injecting drug users.

Authors:  Judith A Hahn; Jennifer L Evans; Peter J Davidson; Paula J Lum; Kimberly Page
Journal:  Addiction       Date:  2010-05-14       Impact factor: 6.526

Review 7.  Global epidemiology and genotype distribution of the hepatitis C virus infection.

Authors:  Erin Gower; Chris Estes; Sarah Blach; Kathryn Razavi-Shearer; Homie Razavi
Journal:  J Hepatol       Date:  2014-07-30       Impact factor: 25.083

8.  Risk behaviors after hepatitis C virus seroconversion in young injection drug users in San Francisco.

Authors:  Judith I Tsui; Eric Vittinghoff; Judith A Hahn; Jennifer L Evans; Peter J Davidson; Kimberly Page
Journal:  Drug Alcohol Depend       Date:  2009-07-31       Impact factor: 4.492

9.  Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters.

Authors:  Zhi Xia Dong; Hui Juan Zhou; Jian Hua Wang; Xiao Gang Xiang; Yan Zhuang; Si Min Guo; Hong Lian Gui; Gang De Zhao; Wei Liang Tang; Hui Wang; Qing Xie
Journal:  J Dig Dis       Date:  2012-11       Impact factor: 2.325

10.  The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users.

Authors:  Carl Latkin; Deborah Donnell; Ting-Yuan Liu; Melissa Davey-Rothwell; David Celentano; David Metzger
Journal:  Addiction       Date:  2013-01-30       Impact factor: 6.526

View more
  1 in total

1.  Hepatitis C Resistance-Associated Substitutions Among People Who Inject Drugs Treated With Direct-Acting Antiviral-Containing Regimens.

Authors:  Matthew J Akiyama; Lindsey Riback; Jacqueline D Reeves; Yolanda S Lie; Linda Agyemang; Brianna L Norton; Julia H Arnsten; Alain H Litwin
Journal:  Open Forum Infect Dis       Date:  2021-09-30       Impact factor: 3.835

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.